文献速递脑血管病认知障碍与痴呆

血浆炎症生物标志物与卒中后认知障碍相关:Nor-COAST研究

Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study.
PubMed 文献 · Stroke · 2023-04-07

Nor-COAST前瞻性多中心观察性队列纳入455例缺血性卒中幸存者,分析基线与3、18个月血浆TCC及20种细胞因子与3、18、36个月MoCA评分的关联。基线7种标志物浓度越高与36个月MoCA评分越低显著相关,TCC、IL-6、MIP-1α在3、18、36个月均相关(P<0.01),3个月标志物与18或36个月MoCA无显著关联。

要点

  • 基线7种血浆炎症标志物浓度越高,36个月MoCA评分越低。
  • 基线及18个月的TCC、IL-6、MIP-1α与MoCA关联尤其强。
  • 3个月时的炎症标志物与18或36个月MoCA评分无显著关联。

核心结论

  • 血浆炎症生物标志物浓度越高与卒中后36个月内MoCA评分越低相关,以卒中急性期测得的标志物最为明显。

研究设计与样本

  • Nor-COAST为前瞻性观察性多中心队列研究,纳入2015至2017年因急性卒中住院的患者。

主要发现

  • 共纳入455例缺血性卒中幸存者,基线7种标志物浓度较高与36个月MoCA评分较低显著相关。
  • 基线TCC、IL-6和MIP-1α与3、18和36个月MoCA评分相关(P<0.01)。
  • 3个月时无任何标志物与18或36个月MoCA评分显著相关,18个月时3种标志物浓度较高与36个月MoCA评分较低相关(P<0.01)。
  • 基线TCC以及基线和18个月测得的IL-6、MIP-1α与MoCA关联尤其强(P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammation is proposed to be involved in the pathogenesis of poststroke cognitive impairment. The aim of this study was to investigate associations between concentrations of systemic inflammatory biomarkers after ischemic stroke and poststroke cognitive impairment. METHODS: The Nor-COAST study (Norwegian Cognitive Impairment After Stroke) is a prospective observational multicenter cohort study, including patients hospitalized with acute stroke between 2015 and 2017. Inflammatory biomarkers, including the TCC (terminal C5b-9 complement complex) and 20 cytokines, were analyzed in plasma, collected at baseline, 3-, and 18 months poststroke, using ELISA and a multiplex assay. Global cognitive outcome was assessed with the Montreal Cognitive Assessment (MoCA) scale. We investigated the associations between plasma inflammatory biomarkers at baseline and MoCA score at 3-, 18-, and 36-month follow-ups; the associations between inflammatory biomarkers at 3 months and MoCA score at 18- and 36-month follow-ups; and the association between these biomarkers at 18 months and MoCA score at 36-month follow-up. We used mixed linear regression adjusted for age and sex. RESULTS: We included 455 survivors of ischemic stroke. Higher concentrations of 7 baseline biomarkers were significantly associated with lower MoCA score at 36 months; TCC, IL (interleukin)-6, and MIP (macrophage inflammatory protein)-1α were associated with MoCA at 3, 18, and 36 months (P<0.01). No biomarker at 3 months was significantly associated with MoCA score at either 18 or 36 months, whereas higher concentrations of 3 biomarkers at 18 months were associated with lower MoCA score at 36 months (P<0.01). TCC at baseline and IL-6 and MIP-1α measured both at baseline and 18 months were particularly strongly associated with MoCA (P<0.01). CONCLUSIONS: Higher concentrations of plasma inflammatory biomarkers were associated with lower MoCA scores up to 36 months poststroke. This was most pronounced for inflammatory biomarkers measured in the acute phase following stroke. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02650531.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Sandvig HV, Aam S, Alme KN, et al. Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study. Stroke. 2023. PMID: 37026459. doi:10.1161/STROKEAHA.122.041965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。